Nutrien Ltd. (NTR)
Nutrien mines and manufactures crop nutrients and also sells crop inputs directly to farmers through its own retail network. It is a corporation incorporated under the Canada Business Corporations Act, with its registered and head office in Saskatoon, Saskatchewan. The upstream side mines, processes and manufactures the three essential crop nutrients for fertilizer, potash, nitrogen and phosphate, with manufacturing assets primarily in North America; the downstream side is the Retail segment. Financial information is presented in US dollars.
Nutrien Ltd. files a 40-F with the SEC once a year, in US dollars. In the year to 31 December 2025 it reported revenue of USD 26,885 million, up 3.5% on the year before. Its profit attributable to shareholders was USD 2,267 million, up 236.4%, and diluted earnings per share USD 4.66.
Nutrien (NTR) in brief
Nutrien (NTR) reported revenue of USD 26.9 billion for the year to 31 December 2025, up 3.5% on the year before.
Read more
Profit attributable to shareholders was USD 2.3 billion and diluted earnings per share USD 4.66. Revenue was USD 26.0 billion in 2024, USD 29.1 billion in 2023, USD 37.9 billion in 2022 and USD 27.7 billion in 2021. Profit attributable to shareholders in the same years was USD 674 million, USD 1.3 billion, USD 7.7 billion and USD 3.2 billion. Revenue grew 5.2% a year, compounded, over the five years to 2025. At the close of 10 November 2026 the market cap of Nutrien was $34.8 billion, 15.5 times its earnings for 2025.The share in the US
| Last close | $72.17 on 10 November 2026 |
| 52-week range | $55.06 (20 November 2025) to $83.94 (12 March 2026) |
| Over one year | up 22.4% |
| Market cap | $34.8 billion: 481,962,233 shares outstanding at 31 December 2025 (40-F), each US share standing for one ordinary share |
| P/E, latest fiscal year | 15.5: the last close over diluted EPS for the year to Dec 2025, USD 4.66 per ordinary share. The company reports once a year, so this is the latest fiscal year, not the last four quarters. |
US dollars per share as it trades in the US; the market cap and the P/E are worked out here, not filed. Prices from IEX, for splits.
Ratios
From the latest annual report, the year to Dec 2025, in dollars
ROE9.0%
ROCE10.4%
Operating margin13.9%
Net margin8.4%
FCF margin7.9%
Interest cover5.44
Debt to equity0.42
Cash conversion1.77
Share count, last 12 months-1.6%
Sales CAGR, 3 years-10.8%
Profit CAGR, 3 years-33.4%
EPS$4.66
At the close of 10 November 2026
Price$72.17
Market cap$34.8 billion
Stock P/E15.49
Price to book1.37
EV / EBITDAn/a
Dividend yield3.1%
Market cap / sales1.29
52-week high$83.94
52-week low$55.06
Price, 1 year22.4%
Price CAGR, 3 yearsn/a
Price CAGR, 5 yearsn/a
Worked from the filed figures; hover a name for the formula.
Read more
The priced ones use the latest price, the last regular-hours trade on IEX. Debt to equity here stands on the borrowing lines of Nutrien Ltd.'s balance sheet, added together, finance leases inside them only where the company puts them there; operating leases are a separate line. Nothing here is a valuation or a view.NTRgreeksoup.ai
Daily prices to 10 November 2026, adjusted for splits; from 28 September 2026 each day's price is the last regular-hours trade on IEX.
Read more
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Day by day for the last three years; before that one point a week, carrying the week's last close and its average daily volume, so a volume bar means the same thing across the whole series; the bars sit under the price on their own scale, on the right. The moving averages need consecutive days and are drawn from the daily part. This company reports once a year, so every view here moves once a year, on the day each annual report was filed, and holds until the next. P/E is the close over the year's EPS per US share: the EPS as filed. Sales and margin are each year's revenue and its operating margin. EV/EBITDA, price to book and market cap to sales set the close against that year's balance sheet and its share count per US share. The dashed line is the median over the range shown. Drawn in your browser; the range and overlay you pick are remembered here only.The public record on NTR
| Dividends | $2.16 a share in FY2024 |
| Filings | 27 in twelve months: 22 reports on Form 6-K, most often nutrien Declares Quarterly Dividend of US$0.55 per Share (3); nutrien Reports Third Quarter 2026 Results (1); nutrien Provides Update on Trinidad Nitrogen Operations (1); nutrien Reports Second Quarter 2026 Results (1); nutrien Cautions Investors Regarding Ocehan LLC’s Below Market “Mini-Tender” Offer (1) |
| Planned insider sales | no Form 144 notice in twelve months |
| Options tape | put/call 0.64 by open interest at the 10 November 2026 close; the straddle prices a 2.7% move to 13 November 2026 |
| 13F holders | 734 funds reported a position for the quarter to 30 June 2026; largest Royal Bank of Canada |
| Congress | 0 House trades disclosed in six months |
| Short interest | 8.7 million shares short, 3.56 days to cover at 30 October 2026 |
Income statement (profit and loss), 9 fiscal years
Play it forward: change any box and its column follows; every box opens at the company's own record, shown under the row's name, and says when you set it outside every year in the table.
Read more
Each column runs from the latest year filed to the year chosen in its heading, at a yearly rate. Sales growth starts at the company's own five-year rate and eases a third of the way each year toward the median of the 58 peers in Chemicals (5.3% a year), because a rate far from the rest rarely lasts. Before you open a year, the strip reads today's price backwards: the yearly sales growth that brings EPS, at the company's own margins, tax and share count, to today's price at the median P/E of the 33 peers in Chemicals (23.4). Low, middle, high opens three columns for one year: the low and high cases take the company's own weaker and stronger years in the table (the lower and upper quarter of its yearly sales growth and operating margin) and the lower and higher of today's P/E and its peers'; the middle is the boxes as they open. Net income keeps the share that went to minority holders; EPS is net income over the diluted shares, on the same basis as the EPS in the table. The price is that year's EPS at the P/E you set, and the yearly return runs from today's price to the year's end. These are your assumptions and your arithmetic, not an estimate of ours. The link carries your columns, so you can send the forecast to someone.| Year to | Dec 2017 | Dec 2018 † | Dec 2019 † | Dec 2020 † | Dec 2021 | Dec 2022 † | Dec 2023 † | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,547 | 19,636 | 20,084 | 20,908 | 27,712 | 37,884 | 29,056 | 25,972 | 26,885 |
| Cost of sales | 3,316 | 13,380 | 13,814 | 14,814 | 17,452 | 21,588 | 19,608 | 17,486 | 17,602 |
| Gross profit | 694 | 5,392 | 5,502 | 5,239 | 9,409 | 15,424 | 8,474 | 7,530 | 8,347 |
| Operating profit | 209 | 414 | 1,862 | 902 | 4,781 | 10,809 | 2,745 | 1,856 | 3,736 |
| Finance costs | 238 | 538 | 554 | 520 | 613 | 563 | 793 | 720 | 687 |
| Profit before tax | -29.0 | -124 | 1,308 | 382 | 4,168 | 10,246 | 1,952 | 1,136 | 3,049 |
| Income tax | -183 | -93.0 | 316 | -77.0 | 989 | 2,559 | 670 | 436 | 752 |
| Profit for the year | 327 | 3,573 | 992 | 459 | 3,179 | 7,687 | 1,282 | 700 | 2,297 |
| Profit attributable to shareholders | 327 | 3,573 | 992 | 459 | 3,153 | 7,660 | 1,258 | 674 | 2,267 |
| Filing | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F |
USD million, from each year's annual report on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read more
A line the company does not file under the standard tag is left out rather than estimated. A year marked † shows the figure as the company restated it in a later annual report (Dec 2018, Dec 2019, Dec 2020, Dec 2022, Dec 2023); the first-filed figure is in the CSV. Profit attributable to shareholders is the profit for the year; the company reports no minority interests. Profit for the year includes the part that belongs to minority shareholders; profit attributable to shareholders is the part EPS is struck on. Each year links to its own page.| Year to | Dec 2017 | Dec 2018 † | Dec 2019 † | Dec 2020 † | Dec 2021 | Dec 2022 † | Dec 2023 † | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS | 0.39 | 5.72 | 1.70 | 0.81 | 5.52 | 14.18 | 2.53 | 1.36 | 4.66 |
| Basic EPS | 0.39 | 5.72 | 1.70 | 0.81 | 5.53 | 14.22 | 2.53 | 1.36 | 4.66 |
| Filing | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F |
USD per ordinary share, as filed. One US-listed share can stand for more or fewer ordinary shares; the P/E above puts the two on the same basis.
Revenue by segment
| Dec 2017 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | Share of the parts, latest year | |
|---|---|---|---|---|---|---|---|---|
| Retail | n/a | 14,785 | 17,734 | 21,350 | 19,542 | 17,832 | 17,620 | 61.7% |
| Nitrogen | 1,469 | 3,200 | 5,137 | 8,048 | 4,735 | 4,134 | 4,739 | 16.6% |
| Potash | 1,868 | 2,513 | 4,407 | 8,199 | 4,166 | 3,378 | 3,995 | 14.0% |
| Phosphate | n/a | 1,443 | 2,046 | 2,620 | 2,263 | 1,888 | 1,958 | 6.9% |
| Corporate and Others Segment | n/a | 82.0 | 0.0 | 0.0 | 0.0 | 195 | 246 | 0.9% |
| Phosphate and Sulfate | 1,284 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales between segments, taken out | -74.0 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Eliminations | n/a | -1,115 | -1,612 | -2,333 | -1,650 | -1,455 | -1,673 | n/a |
Retail FY2020 to FY2025NitrogenPotashPhosphate FY2020 to FY2025Corporate and Others Segment FY2020 to FY2025Phosphate and Sulfate FY2017
USD billion; hover a block for its figure and share; the figure over a bar is its parts, before the lines named below; a part named with years is one the company split its revenue into only then
USD million, from the latest 40-F, in the company's own words. A year is shown only where the parts add up to the revenue above.
Cash flow statement
Follow the cash: free cash flow, which is operating cash flow less capital expenditure and share-based pay, for five years and after, in today's money.
Read more
The figure a share at the top is what a discounted cash flow calls intrinsic value, worked out on your assumptions. Everything after year five is one sum: the sixth year's cash, growing at the long-run rate every year after, added up and brought back to today's money. Each year runs from the latest year filed. Sales growth opens where Play it forward does: the company's own five-year rate, easing a third of the way each year toward the median of the 58 peers in Chemicals (5.3% a year); change a year and the years after it follow. Operating cash flow, capital expenditure and share-based pay open at the company's own median share of sales over its last five years, shown under each row. Share-based pay is taken off because operating cash flow adds back the shares paid to staff as if they cost nothing; set it to 0 to leave it in. Capital spending counts every capital line the company files in its cash flow, such as equipment it leases to customers, software, wells or property it develops, named under the row, while the Capital expenditure row in the table below stays the one line as filed; buying a business, securities or a finished property is not counted. The discount rate opens at 10%, about what US stocks have returned a year over the long run, so it is the return you give up by holding this company instead of the market; the growth after year five opens at 3%, a little under the US economy's long-run growth in dollars, because no company outgrows it for ever. Net debt is the debt and short-term borrowings less the cash on the latest balance sheet that shows the debt; the figure per share divides what is left by the diluted share count. These are your assumptions and your arithmetic, not an estimate of ours. The link carries them, so you can send them to someone.| Year to | Dec 2017 | Dec 2018 † | Dec 2019 † | Dec 2020 † | Dec 2021 | Dec 2022 † | Dec 2023 † | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1,225 | 2,052 | 3,665 | 3,323 | 3,886 | 8,110 | 5,066 | 3,535 | 4,007 |
| Purchase of property, plant and equipment | 651 | 1,405 | 1,728 | 1,423 | 1,777 | 2,253 | 2,415 | 2,025 | 1,882 |
| Free cash flow | 574 | 647 | 1,937 | 1,900 | 2,109 | 5,857 | 2,651 | 1,510 | 2,125 |
| Cash from investing | -652 | 3,887 | -2,798 | -1,204 | -1,807 | -2,901 | -2,958 | -2,133 | -1,372 |
| Cash from financing | -489 | -3,705 | -2,479 | -1,339 | -3,003 | -4,731 | -2,061 | -1,453 | -2,817 |
| Depreciation and amortisation | -692 | -1,592 | -1,799 | 1,989 | 1,951 | 2,012 | 2,169 | 2,339 | 2,369 |
| Buybacks | n/a | 1,800 | 1,930 | 160 | 1,035 | 4,520 | 1,047 | 184 | 551 |
| Dividends paid | 330 | 952 | 1,022 | 1,030 | 1,045 | 1,031 | 1,032 | 1,060 | 1,061 |
| Filing | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F |
USD million, from the cash flow statement as filed.
Read more
Purchase of property, plant and equipment is the cash line as filed; purchases of intangible assets and acquisitions are not in it. Free cash flow is cash from operations less that purchase, arithmetic on the two filed lines. Cash from investing and from financing are the company's own section totals, below zero where cash went out. Buybacks are the cash paid for the company's own shares.Balance sheet at year end
| Year to | Dec 2017 | Dec 2018 † | Dec 2019 † | Dec 2020 † | Dec 2021 | Dec 2022 † | Dec 2023 † | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Funded by | |||||||||
| Equity attributable to shareholders | 8,303 | 24,425 | 22,907 | 22,365 | 23,652 | 25,818 | 25,156 | 24,407 | 25,323 |
| Non-controlling interests | n/a | n/a | n/a | 38.0 | 47.0 | 45.0 | 45.0 | 35.0 | 42.0 |
| Borrowings, as filed | 4,441 | 9,203 | 10,031 | 10,220 | 9,626 | 10,724 | 11,240 | 11,452 | 10,736 |
| Lease liabilities | n/a | 20.0 | 1,073 | 1,140 | 1,220 | 1,204 | 1,326 | 1,355 | 1,283 |
| Other liabilities | 4,254 | 11,854 | 12,788 | 13,429 | 15,409 | 16,795 | 14,982 | 14,591 | 14,917 |
| Total equity and liabilities | 16,998 | 45,502 | 46,799 | 47,192 | 49,954 | 54,586 | 52,749 | 51,840 | 52,301 |
| Owned | |||||||||
| Property, plant and equipment | 12,971 | 18,796 | 20,335 | 19,660 | 20,016 | 21,767 | 22,461 | 22,604 | 22,747 |
| Goodwill | 97.0 | 11,431 | 11,986 | 12,198 | 12,220 | 12,368 | 12,114 | 12,043 | 12,136 |
| Other intangible assets | 69.0 | 2,210 | 2,428 | 2,388 | 2,340 | 2,297 | 2,217 | 1,819 | 1,667 |
| Cash and cash equivalents | 116 | 2,314 | 671 | 1,454 | 499 | 901 | 941 | 853 | 701 |
| Trade and other receivables | 489 | 3,342 | 3,542 | 3,626 | 5,366 | 6,194 | 5,398 | 5,390 | 5,675 |
| Inventories | 788 | 4,917 | 4,975 | 4,930 | 6,328 | 7,632 | 6,336 | 6,148 | 6,977 |
| Other assets | 2,468 | 2,492 | 2,862 | 2,936 | 3,185 | 3,427 | 3,282 | 2,983 | 2,398 |
| Total assets | 16,998 | 45,502 | 46,799 | 47,192 | 49,954 | 54,586 | 52,749 | 51,840 | 52,301 |
| Filing | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F |
USD million, at each fiscal year end.
Read more
Both totals are the company's own; other liabilities and other assets are each total less the rows shown. Borrowings is the company's own stated total where it files one; it is never added up from its parts here.Ratios on the filed lines
| Year to | Dec 2017 | Dec 2018 † | Dec 2019 † | Dec 2020 † | Dec 2021 | Dec 2022 † | Dec 2023 † | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 15.3% | 27.5% | 27.4% | 25.1% | 34.0% | 40.7% | 29.2% | 29.0% | 31.0% |
| Operating margin | 4.6% | 2.1% | 9.3% | 4.3% | 17.3% | 28.5% | 9.4% | 7.1% | 13.9% |
| Net margin | 7.2% | 18.2% | 4.9% | 2.2% | 11.4% | 20.2% | 4.3% | 2.6% | 8.4% |
| Free cash flow margin | 12.6% | 3.3% | 9.6% | 9.1% | 7.6% | 15.5% | 9.1% | 5.8% | 7.9% |
| Return on year-end equity | 3.9% | 14.6% | 4.3% | 2.1% | 13.3% | 29.7% | 5.0% | 2.8% | 9.0% |
| Effective tax rate | n/a | n/a | 24.2% | -20.2% | 23.7% | 25.0% | 34.3% | 38.4% | 24.7% |
| Filing | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F | 40-F |
Arithmetic on the filed lines of the same year: margins over revenue, return on equity as profit attributable to shareholders over year-end equity, tax over profit before tax.
Questions
What was Nutrien's revenue in 2025?
Nutrien (NTR) reported revenue of USD 26.9 billion for the year to 31 December 2025, up 3.5% on the year before.
How much did Nutrien earn in 2025?
Profit attributable to shareholders was USD 2.3 billion for the year to 31 December 2025, and diluted earnings per share USD 4.66.
What is Nutrien's P/E ratio?
At the close of 10 November 2026, Nutrien traded at 15.5 times its earnings for 2025.
What is Nutrien's market cap?
The market cap of Nutrien was $34.8 billion at the close of 10 November 2026.
Peers: Chemicals
| Company | Market cap | P/E | ROE | Op. margin | Sales growth TTM | Debt to equity | Div. yield |
|---|---|---|---|---|---|---|---|
| Air Products & Chemicals, Inc. APD | $69.5 billion | n/a | -0.3% | -4.7% | 4.5% | 1.27 | 2.3% |
| Nutrien Ltd. NTR * | $34.8 billion | 15.49 | 9.0% | 13.9% | 3.5% | 0.42 | 3.1% |
| PPG Industries Inc. PPG | $27.5 billion | 17.77 | 18.5% | n/a | 6.4% | 0.81 | 2.3% |
| Dow Inc. DOW | $22.8 billion | n/a | -5.5% | n/a | 4.2% | 1.09 | 6.7% |
| International Flavors & Fragrances Inc. IFF | $20.8 billion | 117.15 | 1.4% | 7.5% | -16.7% | 0.47 | 1.9% |
| DuPont de Nemours, Inc. DD | $20.8 billion | 70.35 | 2.2% | n/a | 3.2% | 0.23 | 1.5% |
| LyondellBasell Industries N.V. LYB | $19.6 billion | 15.29 | 11.6% | 8.6% | -1.8% | 1.10 | 5.7% |
| CF Industries Holdings, Inc. CF | $17.9 billion | 8.64 | 38.1% | 41.6% | 17.9% | 0.56 | 1.7% |
| RPM International Inc. RPM | $13.5 billion | 19.61 | 19.8% | n/a | 6.0% | 0.69 | n/a |
| Mosaic Co. MOS | $7.3 billion | n/a | -9.9% | -5.1% | 0.0% | 0.56 | 3.8% |
| Scotts Miracle-Gro Co. SMG | $3.8 billion | 56.60 | n/a | 11.8% | -2.0% | n/a | 4.1% |
| CVR Partners, LP UAN | $1.2 billion | 11.19 | n/a | 20.6% | 7.3% | n/a | n/a |
All 63 in Chemicals
| Company | Market cap | P/E | ROE | Op. margin | Sales growth TTM | Debt to equity | Div. yield |
|---|---|---|---|---|---|---|---|
| Linde plc LIN | $239.5 billion | 34.62 | 17.8% | 25.3% | 8.2% | 0.68 | 1.2% |
| Air Products & Chemicals, Inc. APD | $69.5 billion | n/a | -0.3% | -4.7% | 4.5% | 1.27 | 2.3% |
| Nutrien Ltd. NTR * | $34.8 billion | 15.49 | 9.0% | 13.9% | 3.5% | 0.42 | 3.1% |
| PPG Industries Inc. PPG | $27.5 billion | 17.77 | 18.5% | n/a | 6.4% | 0.81 | 2.3% |
| Dow Inc. DOW | $22.8 billion | n/a | -5.5% | n/a | 4.2% | 1.09 | 6.7% |
| International Flavors & Fragrances Inc. IFF | $20.8 billion | 117.15 | 1.4% | 7.5% | -16.7% | 0.47 | 1.9% |
| DuPont de Nemours, Inc. DD | $20.8 billion | 70.35 | 2.2% | n/a | 3.2% | 0.23 | 1.5% |
| LyondellBasell Industries N.V. LYB | $19.6 billion | 15.29 | 11.6% | 8.6% | -1.8% | 1.10 | 5.7% |
| CF Industries Holdings, Inc. CF | $17.9 billion | 8.64 | 38.1% | 41.6% | 17.9% | 0.56 | 1.7% |
| RPM International Inc. RPM | $13.5 billion | 19.61 | 19.8% | n/a | 6.0% | 0.69 | n/a |
| Albemarle Corp. ALB | $11.2 billion | 22.93 | 6.5% | 10.0% | 24.4% | 0.18 | 1.7% |
| Solstice Advanced Materials Inc. SOLS | $10.2 billion | 31.86 | 20.8% | n/a | n/a | 1.48 | n/a |
| Westlake Corp. WLK | $8.1 billion | n/a | -5.2% | -3.8% | -0.4% | 0.58 | 3.4% |
| Axalta Coating Systems Ltd. AXTA | $8.0 billion | 24.12 | 12.7% | 12.4% | 0.1% | 1.14 | n/a |
| Element Solutions Inc. ESI | $7.9 billion | 38.53 | 7.1% | 11.7% | 39.6% | 0.72 | 1.0% |
| Eastman Chemical Co. EMN | $7.5 billion | 11.62 | 10.3% | n/a | 0.3% | 0.83 | 5.1% |
| Mosaic Co. MOS | $7.3 billion | n/a | -9.9% | -5.1% | 0.0% | 0.56 | 3.8% |
| Newmarket Corp. NEU | $6.4 billion | 14.11 | 23.7% | 20.2% | 0.9% | 0.43 | 1.7% |
| Hexcel Corp. HXL | $6.2 billion | 36.64 | 12.9% | 12.2% | 7.6% | 0.71 | 0.9% |
| Balchem Corp. BCPC | $5.5 billion | 32.72 | 12.9% | 20.7% | 9.4% | 0.11 | 0.6% |
| Celanese Corp. CE | $5.4 billion | 20.64 | 6.1% | 7.9% | 1.4% | 2.74 | 0.2% |
| Sensient Technologies Corp. SXT | $5.2 billion | 30.51 | 13.2% | 14.5% | 9.5% | 0.61 | 1.4% |
| Perimeter Group Inc. PRM | $5.0 billion | 236.23 | 4.2% | 14.5% | 30.7% | 0.91 | n/a |
| CSW Industrials, Inc. CSW | $4.6 billion | 36.58 | 11.4% | 16.9% | 30.0% | 0.68 | 0.4% |
| Avient Corp. AVNT | $4.2 billion | 23.45 | 7.3% | 9.7% | 5.2% | 0.74 | 2.4% |
| Scotts Miracle-Gro Co. SMG | $3.8 billion | 56.60 | n/a | 11.8% | -2.0% | n/a | 4.1% |
| Cabot Corp. CBT | $3.7 billion | 20.28 | 11.8% | 13.6% | -4.7% | 0.79 | 2.5% |
| WD-40 Co. WDFC | $3.0 billion | 37.07 | 30.2% | 15.8% | 11.0% | 0.32 | 1.8% |
| H.B. Fuller Co. FUL | $2.7 billion | 14.14 | 9.1% | n/a | 1.5% | 0.95 | 1.8% |
| Rogers Corp. ROG | $2.3 billion | 50.62 | 3.7% | 7.9% | 6.7% | 0.00 | n/a |
| Ingevity Corp. NGVT | $2.1 billion | 35.75 | 94.9% | n/a | -6.5% | 18.18 | n/a |
| Chemours Co. CC | $2.0 billion | n/a | -99.4% | 0.6% | 0.1% | 24.73 | 2.6% |
| Olin Corp. OLN | $2.0 billion | n/a | -13.1% | -1.9% | -0.7% | 1.75 | 4.6% |
| Minerals Technologies Inc. MTX | $1.9 billion | n/a | -4.3% | -1.6% | 4.8% | 0.61 | 0.8% |
| Innospec Inc. IOSP | $1.9 billion | 13.71 | 10.2% | 8.8% | 4.7% | 0.00 | 2.2% |
| Huntsman Corp. HUN | $1.6 billion | n/a | -6.5% | 0.0% | 6.5% | 0.77 | 3.7% |
| REX American Resources Corp. REX | $1.3 billion | 10.92 | 17.9% | n/a | 1.3% | 0.00 | n/a |
| CVR Partners, LP UAN | $1.2 billion | 11.19 | n/a | 20.6% | 7.3% | n/a | n/a |
| Ecovyst Inc. ECVT | $1.2 billion | 33.31 | 6.0% | 8.5% | 44.6% | 0.81 | n/a |
| Green Plains Inc. GPRE | $967 million | 5.59 | 20.7% | 10.7% | -19.1% | 0.50 | n/a |
| Kronos Worldwide Inc. KRO | $945 million | n/a | -4.8% | 2.2% | 8.7% | 0.69 | 2.4% |
| Flotek Industries Inc. FTK | $922 million | 31.84 | 21.6% | 13.2% | 59.3% | 0.54 | n/a |
| FMC Corp. FMC | $879 million | n/a | n/a | -97.0% | -22.0% | n/a | 32.2% |
| LSB Industries, Inc. LXU | $805 million | 18.03 | 8.2% | 11.2% | 13.0% | 0.79 | n/a |
| Westlake Chemical Partners LP WLKP | $757 million | n/a | n/a | 29.0% | 9.4% | n/a | n/a |
| Luxfer Holdings plc LXFR | $464 million | n/a | n/a | n/a | n/a | 0.26 | n/a |
| Valhi Inc. VHI | $462 million | 326.00 | 0.1% | 6.1% | 9.0% | 0.52 | 2.0% |
| Tronox Holdings plc TROX | $455 million | n/a | -44.9% | -5.1% | 12.0% | 2.85 | 7.0% |
| PureCycle Technologies, Inc. PCT | $432 million | n/a | -1,014.3% | -1,313.8% | 141.7% | 7.93 | n/a |
| AdvanSix Inc. ASIX | $416 million | n/a | -2.9% | n/a | 8.4% | 0.34 | 4.2% |
| NLI Holdings, Inc. NL | $350 million | n/a | -1.3% | 9.8% | 4.3% | 0.00 | 5.5% |
| Gevo, Inc. GEVO | $348 million | n/a | -61.1% | -68.2% | 80.1% | 0.56 | n/a |
| Alto Ingredients, Inc. ALTO | $298 million | 6.00 | 18.6% | 2.7% | 4.1% | 0.21 | n/a |
| ASP Isotopes Inc. ASPI | $257 million | n/a | -44.3% | -321.1% | 573.4% | 0.99 | n/a |
| Orion S.A. OEC | $236 million | n/a | -8.1% | 4.0% | 0.9% | 2.48 | 1.9% |
| Lightbridge Corp. LTBR | $176 million | n/a | -11.7% | n/a | n/a | 0.00 | n/a |
| FutureFuel Corp. FF | $137 million | n/a | -20.5% | -13.2% | 71.2% | 0.00 | n/a |
| Arq, Inc. ARQ | $130 million | n/a | -28.7% | -38.8% | 7.3% | 0.17 | n/a |
| Comstock Inc. LODE | $127 million | n/a | -35.6% | -3,535.2% | -52.2% | 0.08 | n/a |
| Ascent Industries Co. ACNT | $122 million | n/a | -1.2% | -2.7% | -6.1% | 0.01 | 0.0% |
| Aemetis, Inc. AMTX | $116 million | n/a | n/a | 7.2% | 23.6% | n/a | n/a |
| Codexis, Inc. CDXS | $92 million | n/a | -93.2% | -35.6% | 35.9% | 1.24 | n/a |
| Flexible Solutions International Inc. FSI | $86 million | n/a | -8.4% | -2.6% | -4.7% | 0.16 | n/a |
4 companies share its SEC industry code (Agricultural Chemicals); the rest are the names nearest in size in its wider industry, Chemicals, one of the Fama-French 48 industries, a published grouping of SEC industry codes.
Read more
By market capitalisation; a click on a heading sorts by it, largest first, and a second click turns it round. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close; a name marked * is a foreign company that files once a year, on its latest fiscal year.Annual reports on EDGAR
| Form | Year to | Filed | |
|---|---|---|---|
| 40-F | 31 December 2025 | 27 February 2026 | EDGAR |
| 40-F | 31 December 2024 | 28 February 2025 | EDGAR |
| 40-F | 31 December 2023 | 1 March 2024 | EDGAR |
| 40-F | 31 December 2022 | 24 February 2023 | EDGAR |
| 40-F | 31 December 2021 | 25 February 2022 | EDGAR |
| 40-F | 31 December 2020 | 26 February 2021 | EDGAR |
| 40-F | 31 December 2019 | 28 February 2020 | EDGAR |
| 40-F | 31 December 2018 | 27 February 2019 | EDGAR |